Managing Editor, Senior Health Care News Editor
Jonathan Block is a Managing Editor and Senior Health Care News Editor at Seeking Alpha. He specializes in medicine and healthcare, with a focus on alternative medicine, medical specialties, and the intersection of healthcare with finance and legal affairs. His work has been featured in The National Law Review, NewsBreak, and Defiance Crescent News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jonathan Block's coverage focuses on investment analysis, press releases, and data citations related to sales & marketing and automotive industries. He would likely be interested in pitches that provide in-depth analysis of stock performance, company news, and market trends within these sectors.
Given his focus on investment analysis and citation of data, Jonathan may find value in pitches from financial experts who can offer unique insights into the potential impact of various factors on stock performance or industry trends.
While Jonathan does not have a specific geographic focus mentioned but given the nature of his articles focusing mainly on companies listed in US stock exchanges (NASDAQ: HAS; NYSE: MTN), it is safe to assume he has an interest primarily in the US market.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jonathan Block
Goldman Sachs rates Vaxcyte a buy with $135 price target, highlighting vaccine platform and pneumonia candidate. Read more here.
By: Jonathan Block
Getting lost on Seeking Alpha is annoying; being lost in the stock market is worse. Sign up now. Trending Analysis
By: Jonathan Block
The U.S. FDA revokes Emergency Use Authorization for GSK's sotrovimab as COVID-19 treatment due to Omicron BA.2 variant.
(833) 317-6278 
